China Pharma Holdings Announces $9.8 Million Share Issuance for Patent Acquisition
I'm PortAI, I can summarize articles.
China Pharma Holdings Inc. announced a $9.8 million share issuance to acquire a patent for Ipragliflozin tablets. The company will issue 7,000,000 restricted shares at $1.40 each to Juan Zhang as part of the Technology Transfer Agreement. The shares will be unregistered and offered under Regulation S, exempting them from registration under the Securities Act.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments